Fibroblast growth factor receptor: Difference between revisions
Jump to navigation
Jump to search
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
(12 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
<StructureSection load='1evt' size='350' side='right' scene='' caption='Human fibroblast growth factor receptor 1 ligand-binding domain modules D2 and D3 (pink and yellow) complex with fibroblast growth factor 1 ( | <StructureSection load='1evt' size='350' side='right' scene='54/544712/Cv/1' caption='Human fibroblast growth factor receptor 1 ligand-binding domain modules D2 and D3 (pink and yellow) complex with fibroblast growth factor 1 (cyan and green) and sulfate (PDB code [[1evt]]) '> | ||
== Function == | == Function == | ||
'''Fibroblast growth factor receptors''' (FGFR) are receptors which bind fibroblast growth factors (FGF). Each FGFR can activate several FGFs. Five FGFRs have been identified so far. FGFRs differ in their ligand specificity and tissue distribution. The binding of FGF to FGFR starts a cascade of signaling which influences mitogenesis and differentiation<ref>PMID:8713482</ref>. | '''Fibroblast growth factor receptors''' (FGFR) are receptors which bind [[fibroblast growth factors]] (FGF). Each FGFR can activate several FGFs. Five FGFRs have been identified so far. FGFRs differ in their ligand specificity and tissue distribution. The binding of FGF to FGFR starts a cascade of signaling which influences mitogenesis and differentiation<ref>PMID:8713482</ref>. See also [[Receptor tyrosine kinases]] and [[Kinase-linked, enzyme-linked and related receptors]]. | ||
*'''FGFR2''' is essential for limb induction<ref>PMID:9435295</ref>. | |||
*'''FGFR3''' is involved in skeletal dysplasia<ref>PMID:22045636</ref>. | |||
== Disease == | == Disease == | ||
Mutation in FGFR3 causes achondroplasia and is involved in myeloma. Mutations in FGFR2 cause Crouzon syndrome. | Mutation in FGFR3 causes achondroplasia<ref>PMID:9718331</ref> and is involved in myeloma<ref>PMID:11529856</ref>. Mutations in FGFR2 cause Crouzon syndrome<ref>PMID:7493034</ref>. | ||
== Structural insights == | == Structural insights == | ||
FGFR consist of an extracellular ligand-binding domain (LBD), transmembrane helix domain and cytoplasmic tyrosine kinase activity domain (TKD) with phosphorylated tyrosine designated PTR. FGFR LBD contains 3 immunoglobulin-like domains D1, D2 and D3. | FGFR consist of an extracellular ligand-binding domain (LBD), transmembrane helix domain and cytoplasmic tyrosine kinase activity domain (TKD) with phosphorylated tyrosine designated PTR. FGFR LBD contains 3 immunoglobulin-like domains D1, D2 and D3. | ||
<scene name='54/544712/Cv/2'>Human fibroblast growth factor receptor 1 ligand-binding domain modules D2 and D3 with 2 molecules of fibroblast growth factor 1</scene> (PDB code [[1evt]]). | |||
==3D structures of fibroblast growth factor receptor== | |||
[[Fibroblast growth factor receptor 3D receptor]] | |||
</StructureSection> | |||
== References == | |||
<references/> | |||
[[Category:Topic Page]] | [[Category:Topic Page]] |